Traders Buy Large Volume of InMode Call Options (NASDAQ:INMD)

InMode Ltd. (NASDAQ:INMD) was the recipient of unusually large options trading activity on Friday. Traders acquired 6,539 call options on the company. This is an increase of approximately 127% compared to the typical volume of 2,877 call options.

Analyst Upgrades and Downgrades

INMD has been the subject of a number of research analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of InMode in a research report on Friday, May 3rd. Barclays lowered their price objective on shares of InMode from $34.00 to $33.00 and set an “overweight” rating for the company in a research report on Friday, April 12th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, InMode presently has a consensus rating of “Hold” and a consensus price target of $32.80.

Institutional Investors Weigh In On InMode

Hedge funds have recently added to or reduced their stakes in the business. Principal Securities Inc. acquired a new stake in InMode during the 4th quarter worth approximately $32,000. Sunbelt Securities Inc. acquired a new stake in shares of InMode in the 3rd quarter valued at $47,000. Headlands Technologies LLC raised its holdings in shares of InMode by 118.2% in the 1st quarter. Headlands Technologies LLC now owns 1,916 shares of the healthcare company’s stock valued at $41,000 after purchasing an additional 1,038 shares in the last quarter. Trust Co. of Vermont raised its holdings in shares of InMode by 32.8% in the 4th quarter. Trust Co. of Vermont now owns 2,168 shares of the healthcare company’s stock valued at $48,000 after purchasing an additional 536 shares in the last quarter. Finally, Newbridge Financial Services Group Inc. raised its holdings in shares of InMode by 69.2% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 2,200 shares of the healthcare company’s stock valued at $49,000 after purchasing an additional 900 shares in the last quarter. 68.04% of the stock is currently owned by institutional investors and hedge funds.

InMode Stock Up 2.0 %

InMode stock opened at $18.17 on Friday. The firm has a market cap of $1.53 billion, a PE ratio of 8.61 and a beta of 2.20. InMode has a 52-week low of $16.72 and a 52-week high of $48.25. The company’s 50 day moving average is $18.17 and its two-hundred day moving average is $20.68.

InMode (NASDAQ:INMD) last released its earnings results on Thursday, May 2nd. The healthcare company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.32 by $0.09. The company had revenue of $80.28 million for the quarter, compared to analyst estimates of $80.10 million. InMode had a net margin of 38.84% and a return on equity of 26.15%. On average, equities research analysts anticipate that InMode will post 1.8 earnings per share for the current fiscal year.

InMode Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.